Tue, Oct 07, 2025 | Updated 07:40 IST
Apr 30, 2020
Mumbai (Maharashtra) [India], April 30 : Glenmark Pharmaceuticals said on Thursday it has received approval from the Drug Controller General of India (DCGI) to conduct clinical trials on Favipiravir anti-viral tablets on COVID-19 patients.
Mumbai (Maharashtra) [India], April 30 : Equity benchmark indices were in the green during early hours on Thursday as Asian shares moved up on encouraging early results from a COVID-19 treatment trial.
Apr 29, 2020
More News
Mumbai, (Maharashtra) [India], Apr 29 : IndiGrid, India's first power sector infrastructure investment trust (InvIT), said on Wednesday...
Mumbai (Maharashtra) [India], Apr 29 : GP Petroleums Ltd (GPPL) said on Wednesday it has resumed operations at...
Singapore, April 29 : The official support measures announced for mutual funds in India may struggle to be...